EnteroMedics, Inc. (ETRM) Announces First Commercial Shipment of Maestro Rechargeable System for Proprietary VBLOC Weight Loss Therapy
EnteroMedics announced it has completed the first commercial shipment of the Maestro Rechargeable (RC) System to Device Technologies Pty Ltd., its distribution partner in Australia. This marks a significant milestone for the company, supporting its evolution to a commercial enterprise and its goal of delivering safe, effective, and sustainable weight-loss treatments to patients across the globe. The Maestro RC System delivers VBLOC vagal blocking therapy, which is a first-in-class weight loss treatment that controls both hunger and fullness by blocking the primary nerve regulating the digestive system. VBLOC is designed to be a safer, less invasive treatment for obesity that…